Lexicon Pharmaceuticals
LXRX
LXRX
123 hedge funds and large institutions have $438M invested in Lexicon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12.47% more ownership
Funds ownership: 77.15% → 89.62% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
62% less call options, than puts
Call options by funds: $506K | Put options by funds: $1.34M
Holders
123
Holding in Top 10
1
Calls
$506K
Puts
$1.34M
Top Buyers
| 1 | +$63.6M | |
| 2 | +$8.81M | |
| 3 | +$7.49M | |
| 4 |
Millennium Management
New York
|
+$5.98M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$4.4M |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.25M | |
| 3 | -$858K | |
| 4 |
Renaissance Technologies
New York
|
-$641K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$289K |